Instinct Brothers Co., Ltd. (BIOT)
NASDAQ: BIOT · Real-Time Price · USD
10.15
0.00 (0.00%)
At close: Jul 24, 2026, 4:00 PM
12.50
+2.35 (23.15%)
After-hours: Jul 24, 2026, 5:44 PM EDT
Company Description
Instinct Brothers Co., Ltd. operates as a stem cell technology and regenerative medicine company.
It also engages in the import, sales, management, and delivery of stem cell cosmetics. The company also provides stem cell beauty essence products.
Instinct Brothers Co., Ltd. The company was incorporated in 2015 and is based in Shinagawa, Japan.
Instinct Brothers Co., Ltd.
| Country | Japan |
| Founded | 2017 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Tomoki Nagano |
Contact Details
Address: 3rd Floor West Side, Gotanda Building 6-2-7 Shinagawa, 141-0031 Japan | |
| Website | instinct-bro.com |
Stock Details
| Ticker Symbol | BIOT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 2072186 |
| CUSIP Number | G4860C107 |
| ISIN Number | KYG4860C1078 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Dr. Michael Shleifer Ph.D. | Chairman and Chief Executive Officer |
| Thomas Fratacci | Chief Financial Officer and Treasurer |
| Ivan Jarry | Chief Operating Officer |
| Albert F. Hummel M.B.A. | Chief Investment Officer and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 26, 2026 | 425 | Filing |
| Dec 3, 2025 | EFFECT | Notice of Effectiveness |
| Nov 25, 2025 | POS AM | Post-Effective amendments for registration statement |
| Oct 24, 2025 | F-4/A | Filing |
| Sep 26, 2025 | F-4/A | Filing |
| Sep 17, 2025 | 425 | Filing |
| Sep 9, 2025 | F-4 | Filing |
| Aug 12, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Jun 23, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Jun 13, 2025 | DRS | [Cover] Draft Registration Statement |